COX-2 Script Spike Seen In Patients At Low Risk For NSAID Adverse Events
This article was originally published in The Tan Sheet
Executive Summary
Patients at low risk for gastrointestinal side effects from NSAIDs accounted for a more than 60% jump in COX-2 prescriptions since the introduction of the drug class five years ago, a study in the Jan. 24 Archives of Internal Medicine finds